Arbovax’s Dengue vaccine is now ready for clinical trials

Arbovax’s Dengue vaccine is now ready for clinical trials, WRAL Tech Wire, March 19, 2013. Vaccine developer Arbovax, a spinout from NC State University, is now ready to test how its Dengue fever vaccine candidate works in humans.  Arbovax’s core technology was developed in NCSU’s department of Molecular and Structural Biochemistry. Dennis Brown and Raquel Hernandez, biochemistry, featured.